Ikena Oncology, Inc. (IMA) - Final Profit

IMA (Ikena Oncology) - company brandmark

ImageneBio Inc hedges its investments through a diversified portfolio of oncology drugs. The company's net income clearly demonstrates profit dynamics, where the value -0.05 represents the current figure. Business success is based on the precision of clinical tests and external support. However, the risk of closing inefficient programs and a high cash burn rate make the project's payback hypothetical.

IMA Ikena Oncology, Inc. Company Net Income (07/29/2025 - 10/29/2026)

Comprehensive metric breakdowns and analytics for ikenaoncology.com (IMA)

- market value and analyst target forecast:
Stock Price Ikena Oncology|IMA - Consensus Target
- market capitalization indicators:
Market Value IMA|IMA - Enterprise Value
- business book valuation details:
Net Assets per Share Ikena Oncology|IMA - Company Book Value|Market Cap to Net Assets Ratio ikenaoncology.com|IMA - Aggregate Company Assets
- debt burden and liquidity indicators:
Total Debt to Equity Ratio ImageneBio Inc|IMA - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Ikena Oncology|IMA - Company Debts|Debt to Book Value Ratio IMA|IMA - Company Long-Term Debts|Short-Term Debt Ikena Oncology|Interim Coverage Ratio ikenaoncology.com
- earnings and multiples data:
IMA - Company Net Income
Basic company analysis:Ikena Oncology, Inc.
Core merchandise of ikenaoncology.com

ImageneBio Inc (IMA) focus on targeted immuno-oncology and support from venture capital funds define the specific dynamics of the firm's net income. This indicator reflects the final financial result after all expenses, allowing investors to filter out one-time market noise and assess the business's actual ability to service its obligations, which is critical for determining the asset's fair value amid changing borrowing costs.

Direct competitors

argenx BVBA (ARGX) - Net Profit|Net Income BNTX|ABVX: Final Profit|Net Profit ADMA|Net Financial Result Protagonist Therapeutics, Inc.|Company Net Income Immunovant Corp IMVT|KNSA - Net Income|GRFS - Company Net Income|adaptivebiotech.com (ADPT) - Net Income|CLDX (Celldex Therapeutics, Inc.) - Net Income|Aurinia Pharmaceuticals Inc (AUPH) - Net Profit|Company Net Income BioCryst Pharmaceuticals Inc|Company Profit VERA (Vera Corp)|Net Profit DNTH|PHVS - Company Net Income|Net Profit ABCL (AbCellera Biologics Inc)|Net Financial Result Tourmaline Bio Inc (TRML)|PGEN - Company Net Income|Pharming Corp (PHAR) - Net Income|NKTR: Net Profit|upstreambio.com (UPB) - Net Profit|ZBIO (Zenas Biopharma) - Net Profit|IMNM - Annual Net Income|Net Profit GOSS|KALV - Company Net Income|Company Net Income Septerna Inc SEPN|PVLA: Company Profit|Savara - Net Profit|Company Net Income Rigel Pharma|ANAB: Net Profit|ATXS (Astria Corp) - Company Net Income|ENGN (enGene Holdings Inc.) - Net Profit|rapt.com (RAPT) - Net Financial Result|Company Net Income Aerovate Therapeutics Inc (JBIO)|ACRS - Company Net Income|Kyverna - Net Income|Final Profit TLSA|Cabaletta Bio, Inc. - Net Profit|Net Financial Result ventyxbio.com VTYX|Theratechnologies (THTX) - Company Net Income|Company Profit AVTX|ELDN (Eledon) - Net Profit|Net Income Agenus, Inc (AGEN)|Net Profit CLYM|Net Financial Result zurabio.com|Company Net Income aTyr Pharma ATYR|ADAG - Net Income|Shattuck Therapeutics - Net Profit|EQ - Net Profit|connectbiopharm.com (CNTB) - Company Net Income|Profit After Tax IMUX (Immunic)|ATRA (Atara Biotherapeutics, Inc.) - Net Profit|IFRX: Final Profit|Net Profit XFOR|Net Profit adicetbio.com (ACET)|Company Net Income Celularity CELU|Final Profit INMB|BRNS - Company Net Income|Kezar Life Sciences Inc. (KZR) - Net Income|SABS: Net Profit|Akari Therapeutics, Plc (AKTX) - Net Profit|Net Income ENLV|QTTB: Final Profit|Net Profit GOVX|Net Financial Result Edesa Biotech Inc|Company Net Income iBio Corp IBIO|CARM - Net Income|XTLB - Company Net Income|Bolt Biotherapeutics (BOLT) - Net Income|HCWB (hcwbiologics.com) - Net Income|Aptevo Therapeutics Inc. (APVO) - Net Profit|Company Net Income AIM ImmunoTech|Company Profit ADTX (Aditxt Corp)|Net Profit GRI|XRTX - Company Net Income|Net Profit HIND (Vyome Holdings)|Net Financial Result Revelation Biosciences Inc (REVB)|INDP - Company Net Income|BiondVax Pharmaceuticals (SCNI) - Net Income|CALI: Net Profit|Affimed N.V. (AFMD) - Net Profit|ALLK (Allakos Inc) - Net Profit|HOOK - Annual Net Income|Net Profit IGMS|ITOS - Company Net Income|Company Net Income Ocean Biomedical, Inc. OCEA|TCBP: Company Profit|Third Harmonic Bio, Inc. - Net Profit